CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-14 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-03-14 | VAN NOSTRAND ROBERT L Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-03-14 | Sarlis Nicholas J. Chief Medical Officer and SVP | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-03-14 | Ghiglieri Stephen F Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-03-14 | Burns John Thomas VP, Finance & Corp Controller | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2019-03-14 | Stergiou Angelos M. President and CEO | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2019-03-14 | Varian John Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-03-14 | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2018-12-31 | Stergiou Angelos M. President and CEO | Sale | −23,277 | $1.25 | $29K | 426,858 |
| 2018-09-24 | Lopez Fabio Former Director, 10% holder | Other disposition | −1,521,863 | 0 | ||
| 2018-09-24 | Lopez Fabio Former Director, 10% holder | Other disposition | −676,324 | 0 | ||
| 2018-09-24 | Lopez Fabio Former Director, 10% holder | Other disposition | −325,799 | 0 | ||
| 2018-06-12 | SCHEINBERG DAVID A Director | Grant or award · Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2018-06-12 | Varian John Director | Grant or award · Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2018-06-12 | VAN NOSTRAND ROBERT L Director | Grant or award · Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2018-06-12 | Ghiglieri Stephen F Director | Grant or award · Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2018-06-12 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2018-06-12 | Lopez Fabio Director | Grant or award · Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2018-04-20 | Mack Gene CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-03-14 | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 |
Page 7 of 8 · 141 trades